Abstract
Purpose
Lymph node enlargement in the neck is a common presentation of malignant lymphoma (ML) and requires tissue sampling for accurate diagnosis. Although delayed diagnosis may be critical for some patients, unnecessary biopsy should be avoided wherever possible. This study examined the process for determining the necessity to perform a biopsy and evaluated the value of an open biopsy as a diagnostic tool to enable definite subclassification of the disease.
Methods
The subjects included 20 patients with suspected ML who underwent cervical lymph node extirpation at Okayama Saiseikai general hospital between 2007 and 2010. The decision to perform a biopsy was made based on the results of sonographic evaluation, fine needle aspiration cytology (FNAC), and serum levels of lactate dehydrase (LDH) and soluble interleukin-2 receptor (sIL-2r).
Results
The diagnosis was ML in 15 patients (75%), Castleman’s disease in 1 (5%), and benign lymphadenopathy in 4 (20%).
Conclusions
A lymph node biopsy remains the gold standard for the diagnostic evaluation of ML. Sonographic evaluation combined with serum levels of LDH and sIL-2r is useful in determining the need for biopsy. Many of the cases of ML where it was difficult to determine whether a biopsy should be performed were relatively low grade and critical conditions could be avoided by close observation of the patient.
Similar content being viewed by others
References
Matsumoto F, Itoh S, Ohba S, Yokoi H, Furukawa M, Ikeda K. Biopsy of cervical lymph node. Auris Nasus Larynx. 2009;36:71–4.
Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891–9.
Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985;135:3172–7.
Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers. 2008;13:1–26.
Harrington DS, Patil K, Lai PK, Yasuda NN, Armitage JO, Ip SH, et al. Soluble interleukin 2 receptors in patients with malignant lymphoma. Arch Pathol Lab Med. 1988;112:597–601.
Pfeiffer J, Kayser G, Ridder GJ. Sonography-assisted cutting needle biopsy in the head and neck for the diagnosis of lymphoma: can it replace lymph node extirpation? Laryngoscope. 2009;119:689–95.
Niedzielska G, Kotowski M, Niedzielski A, Dybiec E, Wieczorek P. Cervical lymphadenopathy in children—incidence and diagnostic management. Int J Pediatr Otorhinolaryngol. 2007;71:51–6.
Ahuja AT, Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol. 2005;184:1691–9.
Gritzmann N, Hollerweger A, Macheiner P, Rettenbacher T. Sonography of soft tissue masses of the neck. J Clin Ultrasound. 2002;30:356–73.
Ying M, Ahuja A, Brook F. Accuracy of sonographic vascular features in differentiating different causes of cervical lymphadenopathy. Ultrasound Med Biol. 2004;30:441–7.
Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol. 2004;22:3046–52.
Morris-Stiff G, Cheang P, Key S, Verghese A, Havard TJ. Does the surgeon still have a role to play in the diagnosis and management of lymphomas? World J Surg Oncol. 2008;6:13.
Ferraris AM, Giuntini P, Gaetani GF. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas. Blood. 1979;54:928–32.
Schilling RF, Mcknight B, Crowley JJ. Prognostic value of serum lactic dehydrogenase level in Hodgkin’s disease. J Lab Clin Med. 1982;99:382–7.
Chilosi M, Semenzato G, Vinante F, Menestrina F, Piazzola E, Focchiatti V, et al. Increased levels of soluble interleukin-2 receptor in non-Hodgkin’s lymphomas. Relationship with clinical, histologic, and phenotypic features. Am J Clin Pathol. 1989;92:186–91.
Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M, Devizzi L, Verderio P, Valagussa P. Soluble interleukin-2 receptors (sIL-2R) in Hodgkin’s disease: outcome and clinical implications. Br J Cancer. 1998;77:992–7.
de Kerviler E, de Bazelaire C, Mounier N, Mathieu O, Brethon B, Briere J, et al. Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. Eur Radiol. 2007;17:843–9.
Screaton NJ, Berman LH, Grant JW. Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology. 2002;224:75–81.
Huang PC, Liu CY, Chaung WY, Shih LY, Wan YL. Ultrasound-guided core needle biopsy of cervical lymphadenopathy in patients with lymphoma: the clinical efficacy and factors associated with unsuccessful diagnosis. Ultrasound Med Biol. 2010;36:1431–6.
Ben-Yehuda D, Polliack A, Okon E, Sherman Y, Fields S, Lebenshart P, et al. Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol. 1996;14:2431–4.
Vandervelde C, Kamani T, Varghese A, Ramesar K, Grace R, Howlett DC. A study to evaluate the efficacy of image-guided core biopsy in the diagnosis and management of lymphoma—results in 103 biopsies. Eur J Radiol. 2008;66:107–11.
Conflict of interest
The authors have no conflicts of interest, potential conflicts of financial relationships to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orita, Y., Nose, S., Sato, Y. et al. Cervical lymph node extirpation for the diagnosis of malignant lymphoma. Surg Today 43, 67–72 (2013). https://doi.org/10.1007/s00595-012-0149-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-012-0149-1